Introduction: the challenge of multiresistance

Area of Science:

• Medical microbiology
• Infectious diseases
• Pharmacology

Background:

• Antibiotic resistance is increasing due to rising antibiotic usage.
• Factors driving increased usage include demographic shifts, global development, and medical advancements.
• Effective infection treatment relies on better antimicrobial stewardship, infection control, and novel therapeutic agents.

Purpose of the Study:

• To highlight the escalating challenge of antibiotic resistance.
• To underscore the need for improved antimicrobial utilization and new drug discovery.
• To introduce tigecycline as a potential advancement against Gram-negative pathogens.

Main Methods:

• Review of current trends in antibiotic usage and resistance.
• Analysis of the pipeline for new antimicrobial agents.
• Evaluation of tigecycline's activity profile.

Main Results:

• New agents are emerging for meticillin-resistant Staphylococcus aureus (MRSA).
• Few new antibiotics show significant activity against Gram-negative organisms.
• Tigecycline demonstrates enhanced anti-Gram-negative activity compared to previous analogues.

Conclusions:

• Urgent need for better antimicrobial stewardship and infection control.
• Development of novel antibiotics is crucial to combat resistance.
• Tigecycline represents a valuable addition to the arsenal against Gram-negative bacterial infections.